wada aod9604 prohibited list 2025 World Anti-Doping Agency (WADA) Update Reminder: WADA's 2025 Prohibited List
Description
Oral Administration (if applicable): For oral formulations of AOD-9604 , research has shown bioavailability of approximately 40% in animal studies
& Willing, B
Injections are particularly good in these cases, as they bypass the tract for higher absorption rates than with food or oral supplements
Is the injection site important for lipotropic injections
